30014111000001102: Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Cilostazol\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Cilostazol\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing cilostazol\Cilostazol\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing cilostazol\Cilostazol\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing cilostazol\Product containing cilostazol in oral dose form (medicinal product form)\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing phosphodiesterase inhibitor\Product containing phosphodiesterase 3 inhibitor (product)\Product containing cilostazol\Cilostazol\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing phosphodiesterase inhibitor\Product containing phosphodiesterase 3 inhibitor (product)\Product containing cilostazol\Cilostazol\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing phosphodiesterase inhibitor\Product containing phosphodiesterase 3 inhibitor (product)\Product containing cilostazol\Product containing cilostazol in oral dose form (medicinal product form)\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing cilostazol\Cilostazol\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing cilostazol\Cilostazol\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing cilostazol\Product containing cilostazol in oral dose form (medicinal product form)\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cilostazol in oral dose form (medicinal product form)\Product containing only cilostazol in oral dose form (medicinal product form)\Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet\Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93680701000001110 Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93680801000001118 Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely cilostazol 100 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Cilostazol	false	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Cilostazol	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet	Has AMP	True	Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93680701000001110	Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93680801000001118	Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module